Literature DB >> 16722804

Protein misfolding and human disease.

Niels Gregersen1, Peter Bross, Søren Vang, Jane H Christensen.   

Abstract

Protein misfolding is a common event in living cells. In young and healthy cells, the misfolded protein load is disposed of by protein quality control (PQC) systems. In aging cells and in cells from certain individuals with genetic diseases, the load may overwhelm the PQC capacity, resulting in accumulation of misfolded proteins. Dependent on the properties of the protein and the efficiency of the PQC systems, the accumulated protein may be degraded or assembled into toxic oligomers and aggregates. To illustrate this concept, we discuss a number of very different protein misfolding diseases including phenylketonuria, Parkinson's disease, alpha-1-antitrypsin deficiency, familial neurohypophyseal diabetes insipidus, and short-chain acyl-CoA dehydrogenase deficiency. Despite the differences, an emerging paradigm suggests that the cellular effects of protein misfolding provide a common framework that may contribute to the elucidation of the cell pathology and guide intervention and treatment strategies of many genetic and age-dependent diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16722804     DOI: 10.1146/annurev.genom.7.080505.115737

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  97 in total

1.  Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.

Authors:  Darwin Toledo; Eva Ramon; Mònica Aguilà; Arnau Cordomí; Juan J Pérez; Hugo F Mendes; Michael E Cheetham; Pere Garriga
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 2.  Phenylketonuria: a 21st century perspective.

Authors:  Francjan J van Spronsen
Journal:  Nat Rev Endocrinol       Date:  2010-09       Impact factor: 43.330

Review 3.  Implications of aromatic-aromatic interactions: From protein structures to peptide models.

Authors:  Kamlesh Madhusudan Makwana; Radhakrishnan Mahalakshmi
Journal:  Protein Sci       Date:  2015-10-07       Impact factor: 6.725

4.  Nrf2, a guardian of healthspan and gatekeeper of species longevity.

Authors:  Kaitlyn N Lewis; James Mele; John D Hayes; Rochelle Buffenstein
Journal:  Integr Comp Biol       Date:  2010-05-06       Impact factor: 3.326

Review 5.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

6.  Degradation of a cytosolic protein requires endoplasmic reticulum-associated degradation machinery.

Authors:  Meredith Boyle Metzger; Matthew J Maurer; Beverley M Dancy; Susan Michaelis
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

7.  Disease mechanisms and protein structures in fatty acid oxidation defects.

Authors:  Niels Gregersen; Rikke K J Olsen
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

Review 8.  Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.

Authors:  Zahra Nochi; Rikke Katrine Jentoft Olsen; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

9.  ABCA4 disease progression and a proposed strategy for gene therapy.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Yaroslav Tsybovsky; Sharon B Schwartz; Elizabeth A M Windsor; Alejandro J Roman; Alexander Sumaroka; Janet D Steinberg; Samuel G Jacobson; Edwin M Stone; Krzysztof Palczewski
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

Review 10.  Invasive and non-invasive therapies for Alzheimer's disease and other amyloidosis.

Authors:  Gaurav Pandey; Vibin Ramakrishnan
Journal:  Biophys Rev       Date:  2020-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.